Novel SGLT2 inhibitors with endothelial-protective potential: a combined computational and experimental approach
Journal of Basic and Clinical Physiology and Pharmacology · 21.07.2026 · 37 (4) · 305-314
DOI: 10.1515/jbcpp-2025-0147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, online erschienen am 14.05.2026. Verfasst von Jarritt Romanik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Department of Chemistry, University of Saint Joseph, West Hartford, CT, USA. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Hypoglycemic Agents, Endothelial Cells, Endothelium, Vascular. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objectives
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a class of anti-diabetic drugs with cardiovascular benefits independent of glycemic control, partly via endothelial protection. Identifying novel inhibitors with both high affinity and vascular-protective effects remains a priority.
Methods
Structure-based high-throughput virtual screening (HTVS) of 14 million ligands was performed using Schrödinger Glide. Compounds with better docking scores than empagliflozin (−13.615) were filtered for ADME properties using QikProp. Ten lead compounds were evaluated in human coronary artery endothelial cells under diabetic and ischemia-reperfusion (I/R) models. Assays included glucose uptake, cytotoxicity (LDH), oxidative stress (ROS), and nitrosative stress (NO).
Results
Compound #7 demonstrated the most potent activity, reducing glucose uptake by 55 % (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Department of Chemistry, University of Saint Joseph, West Hartford, CT, USA.
ORCID-Profile: Zhao Li
Zitieren
APA
Romanik, J., Gardella, N., Dematteo, G., Zhao, Y., Moy, T., Brandt, A., & Li, Z. (2026). Novel SGLT2 inhibitors with endothelial-protective potential: a combined computational and experimental approach. Journal of Basic and Clinical Physiology and Pharmacology, 37(4), 305-314. https://doi.org/10.1515/jbcpp-2025-0147
Vancouver
Romanik J, Gardella N, Dematteo G, Zhao Y, Moy T, Brandt A, et al. Novel SGLT2 inhibitors with endothelial-protective potential: a combined computational and experimental approach. Journal of Basic and Clinical Physiology and Pharmacology. 2026;37(4):305-314. doi:10.1515/jbcpp-2025-0147
BibTeX
@article{Romanik2026,
author = {Romanik, Jarritt and Gardella, Nina and Dematteo, Gabriela and Zhao, Yiru and Moy, Timothy and Brandt, Asher and Li, Zhao},
title = {Novel SGLT2 inhibitors with endothelial-protective potential: a combined computational and experimental approach},
journal = {Journal of Basic and Clinical Physiology and Pharmacology},
year = {2026},
volume = {37},
number = {4},
pages = {305--314},
doi = {10.1515/jbcpp-2025-0147}
}
EUVIMED